The American Journal of Medicine
Volume 121, Issue 4 , Pages 279-281, April 2008

Age-related Macular Degeneration: An Update on Treatment

University of Colorado School of Medicine, Department of Ophthalmology, Denver.

Abstract 

Age-related macular degeneration is a chronic disease leading to progressive central vision loss. It is the leading cause of irreversible blindness in the United States, most commonly affecting white Caucasians aged more than 55 years. Typical symptoms include decreased central vision, central scotoma, and metamorphopsia. Patients with acute loss of vision should be promptly referred to an ophthalmologist. New antiangiogenic therapies have significantly improved visual prognosis in these patients.

Keywords: Age-related macular degeneration, Antiangiogenic therapy, Anti-VEGF, Choroidal neovascularization, Retina, Vision loss

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 30.00 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

 Richard D. deShazo, MD, Specialty Editor

PII: S0002-9343(07)01090-X

doi:10.1016/j.amjmed.2007.10.020

The American Journal of Medicine
Volume 121, Issue 4 , Pages 279-281, April 2008